MedTrace Logo

NearWave Optical Molecular Monitoring

NCT06744465 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-02-17

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility of the NearWave optical molecular monitoring system for monitoring therapy progression and predicting pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy (NAC).

Conditions

Interventions

DEVICE

NearWave monitoring

NearWave optical molecular monitoring

Sponsors & Collaborators

  • University of Notre Dame

    collaborator OTHER

  • Elevate Ventures

    collaborator UNKNOWN

  • NearWave Corp.

    collaborator UNKNOWN

  • Indiana University

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-07
Primary Completion
2027-01-31
Completion
2027-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06744465 on ClinicalTrials.gov